Semaglutide
Also known as: Ozempic, Wegovy, Rybelsus
A GLP-1 receptor agonist used for type 2 diabetes and weight management. One of the most studied peptides for metabolic health.
Mechanism of Action
Mimics GLP-1 hormone, stimulating insulin secretion, suppressing glucagon, slowing gastric emptying, and promoting satiety via hypothalamic signaling.
Dosing Protocol
Titration schedule: Start 0.25mg/week for 4 weeks, increase to 0.5mg, then 1mg, up to 2.4mg/week for weight management.
Open peptide calculatorReconstitution
Typically supplied pre-mixed. Research-grade: 5mg vial + 2mL BAC water.
Storage
Refrigerate 2-8°C. Do not freeze. Protect from light.
Side Effects
- ●Nausea
- ●Vomiting
- ●Diarrhea
- ●Constipation
- ●Abdominal pain
Key Research Findings
- ●STEP trials: 15-17% body weight reduction
- ●SELECT trial: 20% cardiovascular risk reduction
- ●Significant HbA1c reduction in diabetes management
Latest Verified Lab Report
No lab reports available for Semaglutide yet.
Community-funded testing results will appear here.
Vendor Trust Leaderboard
Trust leaderboard coming soon.
Vendor rankings based on verified lab test results.
Active Deals
15% off with code at checkout.
10% off with code at checkout.
10% off — discount applied automatically via referral link.
10% off with code at checkout.
Sponsored Ad Space
Advertise with usResearch Use Only
This information is provided for educational and research purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional before using any research compounds.